RSS
13 Jul 2021

Artax Biopharma Granted MHRA Clinical Trial Authorization for AX-158

Author: admintech | Filed under: Press Release

CAMBRIDGE, Mass., July 13, 2021 /PRNewswire/ — Artax Biopharma, Inc., a biotechnology company focused on transforming the treatment of T Cell-mediated diseases, today announced that the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA) has granted clinical trial…

This entry was posted on Tuesday, July 13th, 2021 at 7:12 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»